Stock Comparison

MRNA vs REGN

Moderna Inc and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

MRNA

Moderna Inc

Healthcare

REGN

Regeneron Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$25.14B

$80.55B

P/E (TTM)

—

19.4

Forward P/E

24.5

17.1

Price/Sales

11.3

5.2

Price/Book

3.7

2.5

EV/EBITDA

4.9

13.1

Dividend Yield

—

0.45%

Profitability

Net Margin

-141.43%

29.65%

Operating Margin

-149.01%

24.32%

Return on Equity

-39.00%

14.00%

Return on Assets

-13.30%

6.53%

Growth (YoY)

Revenue Growth

2.10%

16.70%

Earnings Growth

-85.10%

-4.50%

Price & Risk

Beta

0.9

0.2

52-Week High

$81.80

$810.12

52-Week Low

$22.36

$553.38

Analyst Target

$50.84

$833.54

Compare MRNA and REGN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.